Novocure, listed on NASDAQ as NVCR, is an oncology company at the forefront of developing a groundbreaking therapy for solid tumors known as Tumor Treating Fields (TTFields).
Their innovative approach focuses on utilizing TTFields to target and combat solid tumors, offering a promising alternative in the field of oncology.
Generated from their website's infomation